Goldman Sachs cuts Celestica stock price target on capex needs
Goldman Sachs reduced its price target for Celestica (NYSE:CLS) to $435 from $480, citing capex needs, while maintaining a Conviction Buy rating. Celestica's Q3 revenue was $5.83B, EPS $3.30, and it issued 2027 guidance projecting $40B revenue and $21.50 EPS. The stock has fallen 23% over six months but trades at a PEG ratio of 0.39, suggesting undervaluation.
How this was made
The 30-second read
Why it matters
Analyst target reduction signals a shift in valuation expectations, likely prompting short‑term downside.
Market read
The downgrade may trigger sell‑offs in Celestica and could influence sentiment toward similar AI‑hardware suppliers.
What to watch
Potential upside from upcoming 800G demand and custom ASIC programs could offset near‑term capex concerns.
Background
Celestica reported Q3 2026 revenue of $5.83 bn and EPS $3.30, beating expectations, and announced 2027 guidance with high capex needs.
Ticker impact
Goldman Sachs lowered its price target for Celestica to $435 from $480 after the company's Q3 earnings and analyst day.
downward pressure as investors price in the reduced valuation multiple.
The analyst cut reflects concerns over high capex needs and negative free cash flow, which can weigh on the stock.
Market effects
May dampen sentiment for AI‑infrastructure hardware peers as high capex requirements are highlighted.
Limited to North American tech hardware sector.
Modest; primarily affects investors tracking contract manufacturers.
Counterpoint
Some investors may view the price target cut as an overreaction given the strong revenue growth and long‑term cash‑flow outlook.
Key entities
- companyCelestica Inc.
Contract manufacturer focusing on AI infrastructure hardware.
- analystGoldman Sachs
Investment bank that issued the price‑target downgrade.
